Company intelligence / Profile preview

LI COR Biotech

Lincoln, Nebraska, United States

Ownership: Private
Employees: ~350
Development stage: Other

Overview

LI-COR Biosciences is a leading global provider of instrumentation, software, and reagents for biological and environmental research. The company specializes in near-infrared (NIR) fluorescence imaging systems, notably the Odyssey family, which are used for quantitative Western blotting, cell-based assays, and molecular imaging. LI-COR also develops IRDye infrared dyes and reagents that enable high-sensitivity detection in drug discovery and clinical research. Their products are essential for researchers seeking to improve data reproducibility and accuracy in proteomics and small animal imaging.

Modalities: Small moleculeAntibody
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on LI COR Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LI COR Biotech.

Explore the full profile